Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Salinomycin, a polyether ionophoric antibiotic, inhibits adipogenesis.

Szkudlarek-Mikho M, Saunders RA, Yap SF, Ngeow YF, Chin KV.

Biochem Biophys Res Commun. 2012 Nov 30;428(4):487-93. doi: 10.1016/j.bbrc.2012.10.080. Epub 2012 Oct 31.

2.

Survey of American food trends and the growing obesity epidemic.

Shao Q, Chin KV.

Nutr Res Pract. 2011 Jun;5(3):253-9. doi: 10.4162/nrp.2011.5.3.253. Epub 2011 Jun 21.

3.

Prieurianin Causes Weight Loss in Diet-Induced Obese Mice and Inhibits Adipogenesis in Cultured Preadipocytes.

Kablan A, Saunders RA, Szkudlarek-Mikho M, Chin AJ, Bosio RM, Fujii K, Shapiro J, Chin KV.

J Diabetes Metab. 2010 Sep 29;1(101). pii: 1000101.

4.

Modulation of extracellular matrix/adhesion molecule expression by BRG1 is associated with increased melanoma invasiveness.

Saladi SV, Keenen B, Marathe HG, Qi H, Chin KV, de la Serna IL.

Mol Cancer. 2010 Oct 22;9:280. doi: 10.1186/1476-4598-9-280.

5.

The obesity-associated Fto gene is a transcriptional coactivator.

Wu Q, Saunders RA, Szkudlarek-Mikho M, Serna Ide L, Chin KV.

Biochem Biophys Res Commun. 2010 Oct 22;401(3):390-5. doi: 10.1016/j.bbrc.2010.09.064. Epub 2010 Sep 19.

6.

Altered phospholipid transfer protein gene expression and serum lipid profile by topotecan.

Saunders RA, Fujii K, Alabanza L, Ravatn R, Kita T, Kudoh K, Oka M, Chin KV.

Biochem Pharmacol. 2010 Aug 1;80(3):362-9. doi: 10.1016/j.bcp.2010.04.015. Epub 2010 Apr 21.

7.

Interaction of the regulatory subunit of the cAMP-dependent protein kinase with PATZ1 (ZNF278).

Yang WL, Ravatn R, Kudoh K, Alabanza L, Chin KV.

Biochem Biophys Res Commun. 2010 Jan 15;391(3):1318-23. doi: 10.1016/j.bbrc.2009.12.026. Epub 2009 Dec 22.

8.

Inhibition of angiogenesis by extracellular protein kinase A.

Szkudlarek M, Bosio RM, Wu Q, Chin KV.

Cancer Lett. 2009 Sep 28;283(1):68-73. doi: 10.1016/j.canlet.2009.03.027. Epub 2009 Apr 14.

9.

Effects of cardiotonic steroids on dermal collagen synthesis and wound healing.

El-Okdi N, Smaili S, Raju V, Shidyak A, Gupta S, Fedorova L, Elkareh J, Periyasamy S, Shapiro AP, Kahaleh MB, Malhotra D, Xie Z, Chin KV, Shapiro JI.

J Appl Physiol (1985). 2008 Jul;105(1):30-6. doi: 10.1152/japplphysiol.00119.2008. Epub 2008 May 15.

10.

Logistic regression for disease classification using microarray data: model selection in a large p and small n case.

Liao JG, Chin KV.

Bioinformatics. 2007 Aug 1;23(15):1945-51. Epub 2007 May 31.

PMID:
17540680
11.

Application of expression genomics for predicting treatment response in cancer.

Chin KV, Alabanza L, Fujii K, Kudoh K, Kita T, Kikuchi Y, Selvanayagam ZE, Wong YF, Lin Y, Shih WC.

Ann N Y Acad Sci. 2005 Nov;1058:186-95. Review.

PMID:
16394136
12.

Expression profiling of crystal-induced injury in human kidney epithelial cells.

Liang L, Chen J, Vittal R, Selvanayagam ZE, McAteer JA, Deng L, Tischfield J, Chin KV, Sahota A.

Nephron Physiol. 2006;103(1):p53-62. Epub 2005 Dec 21.

PMID:
16374038
14.

Circumventing multidrug resistance in cancer by beta-galactoside binding protein, an antiproliferative cytokine.

Ravatn R, Wells V, Nelson L, Vettori D, Mallucci L, Chin KV.

Cancer Res. 2005 Mar 1;65(5):1631-4.

15.

Effects of tea polyphenols on signal transduction pathways related to cancer chemoprevention.

Hou Z, Lambert JD, Chin KV, Yang CS.

Mutat Res. 2004 Nov 2;555(1-2):3-19. Review.

PMID:
15476848
16.

Prediction of chemotherapeutic response in ovarian cancer with DNA microarray expression profiling.

Selvanayagam ZE, Cheung TH, Wei N, Vittal R, Lo KW, Yeo W, Kita T, Ravatn R, Chung TK, Wong YF, Chin KV.

Cancer Genet Cytogenet. 2004 Oct 1;154(1):63-6.

PMID:
15381375
17.
18.

Extracellular cAMP-dependent protein kinase (ECPKA) in melanoma.

Kita T, Goydos J, Reitman E, Ravatn R, Lin Y, Shih WC, Kikuchi Y, Chin KV.

Cancer Lett. 2004 May 28;208(2):187-91.

PMID:
15142677
20.

Expression genomics of cervical cancer: molecular classification and prediction of radiotherapy response by DNA microarray.

Wong YF, Selvanayagam ZE, Wei N, Porter J, Vittal R, Hu R, Lin Y, Liao J, Shih JW, Cheung TH, Lo KW, Yim SF, Yip SK, Ngong DT, Siu N, Chan LK, Chan CS, Kong T, Kutlina E, McKinnon RD, Denhardt DT, Chin KV, Chung TK.

Clin Cancer Res. 2003 Nov 15;9(15):5486-92.

21.

Application of DNA microarrays in pharmacogenomics and toxicogenomics.

Chin KV, Kong AN.

Pharm Res. 2002 Dec;19(12):1773-8. Review.

PMID:
12523654
22.

Gene expression of TPA induced differentiation in HL-60 cells by DNA microarray analysis.

Zheng X, Ravatn R, Lin Y, Shih WC, Rabson A, Strair R, Huberman E, Conney A, Chin KV.

Nucleic Acids Res. 2002 Oct 15;30(20):4489-99.

23.

Administration of a phorbol ester to patients with hematological malignancies: preliminary results from a phase I clinical trial of 12-O-tetradecanoylphorbol-13-acetate.

Strair RK, Schaar D, Goodell L, Aisner J, Chin KV, Eid J, Senzon R, Cui XX, Han ZT, Knox B, Rabson AB, Chang R, Conney A.

Clin Cancer Res. 2002 Aug;8(8):2512-8.

24.

Reinventing the wheel of cyclic AMP: novel mechanisms of cAMP signaling.

Chin KV, Yang WL, Ravatn R, Kita T, Reitman E, Vettori D, Cvijic ME, Shin M, Iacono L.

Ann N Y Acad Sci. 2002 Jun;968:49-64. Review.

PMID:
12119267
25.

DNA microarray analysis of the expression profiles of luteinized granulosa cells as a function of ovarian reserve.

Chin KV, Seifer DB, Feng B, Lin Y, Shih WC.

Fertil Steril. 2002 Jun;77(6):1214-8.

PMID:
12057731
26.

Role of cAMP-dependent protein kinase in the regulation of DNA repair.

Lee CH, Sidik K, Chin KV.

Cancer Lett. 2001 Aug 10;169(1):51-8.

PMID:
11410325
27.

Monitoring the expression profiles of doxorubicin-induced and doxorubicin-resistant cancer cells by cDNA microarray.

Kudoh K, Ramanna M, Ravatn R, Elkahloun AG, Bittner ML, Meltzer PS, Trent JM, Dalton WS, Chin KV.

Cancer Res. 2000 Aug 1;60(15):4161-6.

28.

Extracellular catalytic subunit activity of the cAMP-dependent protein kinase in prostate cancer.

Cvijic ME, Kita T, Shih W, DiPaola RS, Chin KV.

Clin Cancer Res. 2000 Jun;6(6):2309-17.

29.

Telomere shortening by cisplatin in yeast nucleotide excision repair mutant.

Ishii K, Yang WL, Cvijic ME, Kikuchi Y, Nagata I, Chin KV.

Exp Cell Res. 2000 Feb 25;255(1):95-101.

PMID:
10666338
30.

Transcriptional activation of the cyclin-dependent kinase inhibitor p21 by PML/RARalpha.

Yang WL, Zeng YX, El-Deiry WS, Nason-Burchenal K, Dmitrovsky E, Chin KV.

Mol Cell Biol Res Commun. 1999 May;1(2):125-31.

PMID:
10356361
31.

Nonradioactive detection of DNA repair synthesis.

Lee CH, Sidik K, Chin KV.

Mol Biotechnol. 1999 Jun;11(3):263-6.

PMID:
10503243
32.

Cisplatin sensitivity in cAMP-dependent protein kinase mutants of Saccharomyces cerevisiae.

Cvijic ME, Yang WL, Chin KV.

Anticancer Res. 1998 Sep-Oct;18(5A):3187-92.

PMID:
9858882
34.

The requirement of yeast Ssl2 (Rad25) for the repair of cisplatin-damaged DNA.

Yang WL, Cvijic ME, Ishii K, Chin KV.

Biochem Biophys Res Commun. 1998 Sep 29;250(3):593-7.

PMID:
9784390
35.
36.

Effects of RIalpha overexpression on cisplatin sensitivity in human ovarian carcinoma cells.

Cvijic ME, Chin KV.

Biochem Biophys Res Commun. 1998 Aug 28;249(3):723-7.

PMID:
9731205
37.

Cisplatin resistance in cyclic AMP-dependent protein kinase mutants.

Cvijic ME, Yang WL, Chin KV.

Pharmacol Ther. 1998 May;78(2):115-28. Review.

PMID:
9623882
38.
39.
40.

Cisplatin resistance and regulation of DNA repair in cAMP-dependent protein kinase mutants.

Liu B, Cvijic ME, Jetzt A, Chin KV.

Cell Growth Differ. 1996 Aug;7(8):1105-12.

41.
42.

Gene-specific DNA repair and steady state transcription of the MDR1 gene in human tumor cell lines.

Evans MK, Chin KV, Gottesman MM, Bohr VA.

Oncogene. 1996 Feb 1;12(3):651-8.

PMID:
8637722
43.
44.

Regulation of the multidrug resistance (MDR1) gene expression.

Chin KV, Liu B.

In Vivo. 1994 Nov-Dec;8(5):835-41. Review.

PMID:
7727733
45.

PML, a growth suppressor disrupted in acute promyelocytic leukemia.

Mu ZM, Chin KV, Liu JH, Lozano G, Chang KS.

Mol Cell Biol. 1994 Oct;14(10):6858-67.

46.

Transactivation of the human multidrug resistance (MDR1) gene promoter by p53 mutants.

Nguyen KT, Liu B, Ueda K, Gottesman MM, Pastan I, Chin KV.

Oncol Res. 1994;6(2):71-7.

PMID:
7949467
47.

Function and regulation of the human multidrug resistance gene.

Chin KV, Pastan I, Gottesman MM.

Adv Cancer Res. 1993;60:157-80. Review.

PMID:
8417499
48.

Reduced mRNA levels for the multidrug-resistance genes in cAMP-dependent protein kinase mutant cell lines.

Chin KV, Chauhan SS, Abraham I, Sampson KE, Krolczyk AJ, Wong M, Schimmer B, Pastan I, Gottesman MM.

J Cell Physiol. 1992 Jul;152(1):87-94.

PMID:
1352302
49.

Modulation of activity of the promoter of the human MDR1 gene by Ras and p53.

Chin KV, Ueda K, Pastan I, Gottesman MM.

Science. 1992 Jan 24;255(5043):459-62.

PMID:
1346476
50.

Human hepatocellular carcinoma cell lines exhibit multidrug resistance unrelated to MRD1 gene expression.

Shen DW, Lu YG, Chin KV, Pastan I, Gottesman MM.

J Cell Sci. 1991 Mar;98 ( Pt 3):317-22.

Supplemental Content

Support Center